ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1384

Health-Related Quality of Life in Patients with Ankylosing Spondylitis in the United States

W. Benjamin Nowell1, Regan Reynolds1, Kelly Gavigan1, Shilpa Venkatachalam1, Marie de la Cruz2, Emuella Flood2, Ethan Schwartz2, Beverly Romero2, Yujin Park3 and Alexis Ogdie4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2ICON, Gaithersburg, MD, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), patient-reported outcome measures and quality of life, Work Disability

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Ankylosing spondylitis (AS) is a chronic, systemic, inflammatory disease that affects primarily the sacroiliac joints and spine and can cause irreversible damage. Measuring disease activity and quality of life of AS patients can be complex due to the slow progression and invisible nature of the disease. The objective of this web-based survey was to describe the impact of AS on health-related quality of life (HRQoL) from the US patient perspective.

Methods: US adults aged ≥ 18 years with a self-reported diagnosis of AS were recruited through CreakyJoints (www.CreakyJoints.org), an online patient support community comprising patients with arthritis and arthritis-related diseases and their caregivers, as well as through outreach on social media. Respondents completed a web-based survey that was designed to collect information on sociodemographic characteristics, clinical symptoms, disease burden, and the impact of AS on work productivity and relationships. Survey questions were developed following analysis of qualitative interviews of patients with AS and clinical experts, as well as a targeted literature review. Survey results were compared between men and women using 2-sample t tests for continuous variables and chi squared tests for categorical variables.

Results: Among 235 respondents, 174 (74.0%) were women, and the mean (SD) age was 49.8 (10.7) years. The mean (SD) and median (IQR) time since AS diagnosis was 8.5 (9.3) and 5.0 (2-12) years. Depression (62.1%), anxiety (54.5%), and fibromyalgia (35.7%) were the most commonly reported comorbidities among respondents. Women had significantly higher mean RAPID3 scores and lower PROMIS10 Global Physical and Mental Health T-Scores than men (Table). Approximately 90% of respondents reported either complete or partial unemployment due to AS. Most respondents (71.8%) had difficulty sitting or standing for long hours; other common issues related to work included missed work (47.0%), difficulty doing physical tasks (41.9%), and loss of productivity (41.0%) (Table). Although the impact of AS on work was not significantly different between men and women, the percentage of women with negative impact of AS on work was numerically higher in most categories. The most common impacts of AS on relationships were difficulty spending time with friends (62.6%), lack of understanding from friends and family about AS (54.0%), and difficulty spending time with family (46.8%) (Table).

Conclusion: Whereas the study findings demonstrate a considerable impact of AS on patients’ HRQoL including work productivity and relationships, these topics are often not discussed with their treating physicians, friends, and families. Encouraging patients to share their disease burden with their physicians and caregivers may help to optimize medical care and outcomes in patients with AS.


Disclosure: W. B. Nowell, Global Healthy Living Foundation, 3; R. Reynolds, None; K. Gavigan, Global Healthy Living Foundation, 3; S. Venkatachalam, Global Healthy Living Foundation, 3; M. de la Cruz, ICON plc, 3; E. Flood, ICON plc, 3; E. Schwartz, ICON plc, 3; B. Romero, ICON plc, 3; Y. Park, Novartis Pharmaceuticals Corporation, 3; A. Ogdie, Amgen, AbbVie, BMS, Celgene, Lilly, Novartis, Pfizer, and Takeda, 5,National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatology Research Foundation, Pfizer, and Novartis, 2.

To cite this abstract in AMA style:

Nowell WB, Reynolds R, Gavigan K, Venkatachalam S, de la Cruz M, Flood E, Schwartz E, Romero B, Park Y, Ogdie A. Health-Related Quality of Life in Patients with Ankylosing Spondylitis in the United States [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/health-related-quality-of-life-in-patients-with-ankylosing-spondylitis-in-the-united-states/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-related-quality-of-life-in-patients-with-ankylosing-spondylitis-in-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology